Loading…

Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study

To identify prognostic cut-off values of the hematological indicators NLR and PLR for intubation and death in hospitalized patients with COVID-19. SARS-CoV-2 infection is characterized by lymphocyte and platelet reduction which inversely correlates with disease severity. We retrospectively analyzed...

Full description

Saved in:
Bibliographic Details
Published in:Journal of global antimicrobial resistance. 2024-12, Vol.39, p.75-75
Main Authors: Papanikolopoulou, Amalia, Gourdoupari, Eftychia Eirini Maria, Charalampous, Charalampos, Alexiou, Polyxeni, Rapti, Vasiliki, Livanou, Maria Effrosyni, Kopelia, Maria, Sakka, Vissaria, Syrigos, Konstantinos N, Poulakou, Garyfallia
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 75
container_issue
container_start_page 75
container_title Journal of global antimicrobial resistance.
container_volume 39
creator Papanikolopoulou, Amalia
Gourdoupari, Eftychia Eirini Maria
Charalampous, Charalampos
Alexiou, Polyxeni
Rapti, Vasiliki
Livanou, Maria Effrosyni
Kopelia, Maria
Sakka, Vissaria
Syrigos, Konstantinos N
Poulakou, Garyfallia
description To identify prognostic cut-off values of the hematological indicators NLR and PLR for intubation and death in hospitalized patients with COVID-19. SARS-CoV-2 infection is characterized by lymphocyte and platelet reduction which inversely correlates with disease severity. We retrospectively analyzed patients with COVID-19 pneumonia, sequentially admitted to our Infectious Diseases Department from June 2021 to December 2022 after the implementation of massive SARS-CoV-2 vaccination programs. Two cohorts were compared, with or without immunosuppression, using a propensity score-matching in 1:2 ratio. In total 393 from 400 collected patients (n=131, 33.3% immunocompromised with hematological malignancy or autoimmune condition and n=262, 66.7% non-immunocompromised) were enrolled: female: n=194 (49.4%); mean age 64.7 (SD=16.1). According to WHO criteria 54% (n=211) had severe COVID-19 and 53.9% (n=209) were fully/partially vaccinated against COVID-19. Patients with NLR on day 1 >5.06 and day 4 >6.40 had 5.27 and 9.79 times respectively, greater probability for intubation. Patients with PLR on day 1 >262.2 and day 4 >217.3 had 4.80 and 4.06 times respectively, greater probability for intubation (Table 1, Figure 1a). Patients with NLR on day 1 >4.82 and day 4 >6.41 had 5.84 and 11.35 times respectively, greater probability for death. Patients with PLR on day 1 >229 day 4 >205.4 had 4.73 and 4.49 times respectively, greater probability for death (Table 2, Figure 2). During the 3rd and 4th pandemic wave, cut-off values of the hematological indicators NLR and PLR display strong prognostic potential regarding intubation and death in hospitalized patients with COVID-19.
doi_str_mv 10.1016/j.jgar.2024.10.241
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a58f42fb82ec46c7a65b461e213fc295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213716524004181</els_id><doaj_id>oai_doaj_org_article_a58f42fb82ec46c7a65b461e213fc295</doaj_id><sourcerecordid>S2213716524004181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1621-72c50f44bc47abbf3a8f5829e65f3469815a28defb93777da7b69c5ee4afe32a3</originalsourceid><addsrcrecordid>eNp9UcFu1DAQzQGkVqU_wMlHOHiJHdtJEBe0UFhpRauqcLUmznhx5MYr27vS_lC_E4dFPaHOZaQ3855m3quqt6xesZqpD9Nq2kFc8ZqLAqy4YK-qS85ZQ1um5EV1ndJUl-oF46q9rJ7uYtjNIWVniDlkGqwlR_AHTCRYMuMhx2CdpzlQf3rc_w7mlJFEyC6Qdz-29-8JzCPZe8joMf9_7W5ZsyGS9e2vzRfK-o8EiIGE1IS56HsSsbS0R5PdEUly886XIc4ZI0n5MJ7eVK8t-ITX__pV9fPm68P6O93eftusP2-pYYoz2nIjayvEYEQLw2Ab6KzseI9K2kaovmMSeDeiHfqmbdsR2kH1RiIKsNhwaK6qzVl3DDDpfXSPEE86gNN_gRB3GmLxyqMG2VnB7dBxNEKZFpQchGJYvLaG97Jo8bOWKb-liPZZj9V6CUtPeglLL2EtWAmrkD6dSVi-PDqMOhmHs8HRxWJPOcO9RP8Dw6eh2w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study</title><source>ScienceDirect - Connect here FIRST to enable access</source><source>Elsevier</source><creator>Papanikolopoulou, Amalia ; Gourdoupari, Eftychia Eirini Maria ; Charalampous, Charalampos ; Alexiou, Polyxeni ; Rapti, Vasiliki ; Livanou, Maria Effrosyni ; Kopelia, Maria ; Sakka, Vissaria ; Syrigos, Konstantinos N ; Poulakou, Garyfallia</creator><creatorcontrib>Papanikolopoulou, Amalia ; Gourdoupari, Eftychia Eirini Maria ; Charalampous, Charalampos ; Alexiou, Polyxeni ; Rapti, Vasiliki ; Livanou, Maria Effrosyni ; Kopelia, Maria ; Sakka, Vissaria ; Syrigos, Konstantinos N ; Poulakou, Garyfallia</creatorcontrib><description>To identify prognostic cut-off values of the hematological indicators NLR and PLR for intubation and death in hospitalized patients with COVID-19. SARS-CoV-2 infection is characterized by lymphocyte and platelet reduction which inversely correlates with disease severity. We retrospectively analyzed patients with COVID-19 pneumonia, sequentially admitted to our Infectious Diseases Department from June 2021 to December 2022 after the implementation of massive SARS-CoV-2 vaccination programs. Two cohorts were compared, with or without immunosuppression, using a propensity score-matching in 1:2 ratio. In total 393 from 400 collected patients (n=131, 33.3% immunocompromised with hematological malignancy or autoimmune condition and n=262, 66.7% non-immunocompromised) were enrolled: female: n=194 (49.4%); mean age 64.7 (SD=16.1). According to WHO criteria 54% (n=211) had severe COVID-19 and 53.9% (n=209) were fully/partially vaccinated against COVID-19. Patients with NLR on day 1 &gt;5.06 and day 4 &gt;6.40 had 5.27 and 9.79 times respectively, greater probability for intubation. Patients with PLR on day 1 &gt;262.2 and day 4 &gt;217.3 had 4.80 and 4.06 times respectively, greater probability for intubation (Table 1, Figure 1a). Patients with NLR on day 1 &gt;4.82 and day 4 &gt;6.41 had 5.84 and 11.35 times respectively, greater probability for death. Patients with PLR on day 1 &gt;229 day 4 &gt;205.4 had 4.73 and 4.49 times respectively, greater probability for death (Table 2, Figure 2). During the 3rd and 4th pandemic wave, cut-off values of the hematological indicators NLR and PLR display strong prognostic potential regarding intubation and death in hospitalized patients with COVID-19.</description><identifier>ISSN: 2213-7165</identifier><identifier>DOI: 10.1016/j.jgar.2024.10.241</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>COVID-19 infection ; hospitalized patients ; immunocompromised ; neutrofil-to-lymphocyte ratio ; platelet-to-lymphocyte-ratio</subject><ispartof>Journal of global antimicrobial resistance., 2024-12, Vol.39, p.75-75</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2213716524004181$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3547,27922,27923,45778</link.rule.ids></links><search><creatorcontrib>Papanikolopoulou, Amalia</creatorcontrib><creatorcontrib>Gourdoupari, Eftychia Eirini Maria</creatorcontrib><creatorcontrib>Charalampous, Charalampos</creatorcontrib><creatorcontrib>Alexiou, Polyxeni</creatorcontrib><creatorcontrib>Rapti, Vasiliki</creatorcontrib><creatorcontrib>Livanou, Maria Effrosyni</creatorcontrib><creatorcontrib>Kopelia, Maria</creatorcontrib><creatorcontrib>Sakka, Vissaria</creatorcontrib><creatorcontrib>Syrigos, Konstantinos N</creatorcontrib><creatorcontrib>Poulakou, Garyfallia</creatorcontrib><title>Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study</title><title>Journal of global antimicrobial resistance.</title><description>To identify prognostic cut-off values of the hematological indicators NLR and PLR for intubation and death in hospitalized patients with COVID-19. SARS-CoV-2 infection is characterized by lymphocyte and platelet reduction which inversely correlates with disease severity. We retrospectively analyzed patients with COVID-19 pneumonia, sequentially admitted to our Infectious Diseases Department from June 2021 to December 2022 after the implementation of massive SARS-CoV-2 vaccination programs. Two cohorts were compared, with or without immunosuppression, using a propensity score-matching in 1:2 ratio. In total 393 from 400 collected patients (n=131, 33.3% immunocompromised with hematological malignancy or autoimmune condition and n=262, 66.7% non-immunocompromised) were enrolled: female: n=194 (49.4%); mean age 64.7 (SD=16.1). According to WHO criteria 54% (n=211) had severe COVID-19 and 53.9% (n=209) were fully/partially vaccinated against COVID-19. Patients with NLR on day 1 &gt;5.06 and day 4 &gt;6.40 had 5.27 and 9.79 times respectively, greater probability for intubation. Patients with PLR on day 1 &gt;262.2 and day 4 &gt;217.3 had 4.80 and 4.06 times respectively, greater probability for intubation (Table 1, Figure 1a). Patients with NLR on day 1 &gt;4.82 and day 4 &gt;6.41 had 5.84 and 11.35 times respectively, greater probability for death. Patients with PLR on day 1 &gt;229 day 4 &gt;205.4 had 4.73 and 4.49 times respectively, greater probability for death (Table 2, Figure 2). During the 3rd and 4th pandemic wave, cut-off values of the hematological indicators NLR and PLR display strong prognostic potential regarding intubation and death in hospitalized patients with COVID-19.</description><subject>COVID-19 infection</subject><subject>hospitalized patients</subject><subject>immunocompromised</subject><subject>neutrofil-to-lymphocyte ratio</subject><subject>platelet-to-lymphocyte-ratio</subject><issn>2213-7165</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UcFu1DAQzQGkVqU_wMlHOHiJHdtJEBe0UFhpRauqcLUmznhx5MYr27vS_lC_E4dFPaHOZaQ3855m3quqt6xesZqpD9Nq2kFc8ZqLAqy4YK-qS85ZQ1um5EV1ndJUl-oF46q9rJ7uYtjNIWVniDlkGqwlR_AHTCRYMuMhx2CdpzlQf3rc_w7mlJFEyC6Qdz-29-8JzCPZe8joMf9_7W5ZsyGS9e2vzRfK-o8EiIGE1IS56HsSsbS0R5PdEUly886XIc4ZI0n5MJ7eVK8t-ITX__pV9fPm68P6O93eftusP2-pYYoz2nIjayvEYEQLw2Ab6KzseI9K2kaovmMSeDeiHfqmbdsR2kH1RiIKsNhwaK6qzVl3DDDpfXSPEE86gNN_gRB3GmLxyqMG2VnB7dBxNEKZFpQchGJYvLaG97Jo8bOWKb-liPZZj9V6CUtPeglLL2EtWAmrkD6dSVi-PDqMOhmHs8HRxWJPOcO9RP8Dw6eh2w</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Papanikolopoulou, Amalia</creator><creator>Gourdoupari, Eftychia Eirini Maria</creator><creator>Charalampous, Charalampos</creator><creator>Alexiou, Polyxeni</creator><creator>Rapti, Vasiliki</creator><creator>Livanou, Maria Effrosyni</creator><creator>Kopelia, Maria</creator><creator>Sakka, Vissaria</creator><creator>Syrigos, Konstantinos N</creator><creator>Poulakou, Garyfallia</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202412</creationdate><title>Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study</title><author>Papanikolopoulou, Amalia ; Gourdoupari, Eftychia Eirini Maria ; Charalampous, Charalampos ; Alexiou, Polyxeni ; Rapti, Vasiliki ; Livanou, Maria Effrosyni ; Kopelia, Maria ; Sakka, Vissaria ; Syrigos, Konstantinos N ; Poulakou, Garyfallia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1621-72c50f44bc47abbf3a8f5829e65f3469815a28defb93777da7b69c5ee4afe32a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>COVID-19 infection</topic><topic>hospitalized patients</topic><topic>immunocompromised</topic><topic>neutrofil-to-lymphocyte ratio</topic><topic>platelet-to-lymphocyte-ratio</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papanikolopoulou, Amalia</creatorcontrib><creatorcontrib>Gourdoupari, Eftychia Eirini Maria</creatorcontrib><creatorcontrib>Charalampous, Charalampos</creatorcontrib><creatorcontrib>Alexiou, Polyxeni</creatorcontrib><creatorcontrib>Rapti, Vasiliki</creatorcontrib><creatorcontrib>Livanou, Maria Effrosyni</creatorcontrib><creatorcontrib>Kopelia, Maria</creatorcontrib><creatorcontrib>Sakka, Vissaria</creatorcontrib><creatorcontrib>Syrigos, Konstantinos N</creatorcontrib><creatorcontrib>Poulakou, Garyfallia</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of global antimicrobial resistance.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papanikolopoulou, Amalia</au><au>Gourdoupari, Eftychia Eirini Maria</au><au>Charalampous, Charalampos</au><au>Alexiou, Polyxeni</au><au>Rapti, Vasiliki</au><au>Livanou, Maria Effrosyni</au><au>Kopelia, Maria</au><au>Sakka, Vissaria</au><au>Syrigos, Konstantinos N</au><au>Poulakou, Garyfallia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study</atitle><jtitle>Journal of global antimicrobial resistance.</jtitle><date>2024-12</date><risdate>2024</risdate><volume>39</volume><spage>75</spage><epage>75</epage><pages>75-75</pages><issn>2213-7165</issn><abstract>To identify prognostic cut-off values of the hematological indicators NLR and PLR for intubation and death in hospitalized patients with COVID-19. SARS-CoV-2 infection is characterized by lymphocyte and platelet reduction which inversely correlates with disease severity. We retrospectively analyzed patients with COVID-19 pneumonia, sequentially admitted to our Infectious Diseases Department from June 2021 to December 2022 after the implementation of massive SARS-CoV-2 vaccination programs. Two cohorts were compared, with or without immunosuppression, using a propensity score-matching in 1:2 ratio. In total 393 from 400 collected patients (n=131, 33.3% immunocompromised with hematological malignancy or autoimmune condition and n=262, 66.7% non-immunocompromised) were enrolled: female: n=194 (49.4%); mean age 64.7 (SD=16.1). According to WHO criteria 54% (n=211) had severe COVID-19 and 53.9% (n=209) were fully/partially vaccinated against COVID-19. Patients with NLR on day 1 &gt;5.06 and day 4 &gt;6.40 had 5.27 and 9.79 times respectively, greater probability for intubation. Patients with PLR on day 1 &gt;262.2 and day 4 &gt;217.3 had 4.80 and 4.06 times respectively, greater probability for intubation (Table 1, Figure 1a). Patients with NLR on day 1 &gt;4.82 and day 4 &gt;6.41 had 5.84 and 11.35 times respectively, greater probability for death. Patients with PLR on day 1 &gt;229 day 4 &gt;205.4 had 4.73 and 4.49 times respectively, greater probability for death (Table 2, Figure 2). During the 3rd and 4th pandemic wave, cut-off values of the hematological indicators NLR and PLR display strong prognostic potential regarding intubation and death in hospitalized patients with COVID-19.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.jgar.2024.10.241</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2213-7165
ispartof Journal of global antimicrobial resistance., 2024-12, Vol.39, p.75-75
issn 2213-7165
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a58f42fb82ec46c7a65b461e213fc295
source ScienceDirect - Connect here FIRST to enable access; Elsevier
subjects COVID-19 infection
hospitalized patients
immunocompromised
neutrofil-to-lymphocyte ratio
platelet-to-lymphocyte-ratio
title Prognostic cut-off values of neutrofil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for COVID-19: a case-control retrospective single-center study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A52%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20cut-off%20values%20of%20neutrofil-to-lymphocyte%20ratio%20(NLR)%20and%20platelet-to-lymphocyte%20ratio%20(PLR)%20for%20COVID-19:%20a%20case-control%20retrospective%20single-center%20study&rft.jtitle=Journal%20of%20global%20antimicrobial%20resistance.&rft.au=Papanikolopoulou,%20Amalia&rft.date=2024-12&rft.volume=39&rft.spage=75&rft.epage=75&rft.pages=75-75&rft.issn=2213-7165&rft_id=info:doi/10.1016/j.jgar.2024.10.241&rft_dat=%3Celsevier_doaj_%3ES2213716524004181%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1621-72c50f44bc47abbf3a8f5829e65f3469815a28defb93777da7b69c5ee4afe32a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true